Researchers find new chemotherapy combination shows promise in endometrial cancer
50 percent of patients respond to gemcitabine and cisplatin when used together
22-Mar-2010 -
Researchers from The University of Texas M. D. Anderson Cancer Center report that in a small study of women with advanced or recurrent endometrial cancer, gemcitabine and cisplatin, when used in combination, produced a response rate in fifty percent of patients. Jubilee Brown, M.D., associate ...
chemotherapy
cisplatin
endometrial cancer
+4